[go: up one dir, main page]

ES8704170A1 - Un procedimiento para preparar derivados de guanina - Google Patents

Un procedimiento para preparar derivados de guanina

Info

Publication number
ES8704170A1
ES8704170A1 ES546916A ES546916A ES8704170A1 ES 8704170 A1 ES8704170 A1 ES 8704170A1 ES 546916 A ES546916 A ES 546916A ES 546916 A ES546916 A ES 546916A ES 8704170 A1 ES8704170 A1 ES 8704170A1
Authority
ES
Spain
Prior art keywords
preparation
compounds
hydrogen
guanine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES546916A
Other languages
English (en)
Other versions
ES546916A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8307051A external-priority patent/SE8307051D0/xx
Priority claimed from SE8307052A external-priority patent/SE8307052D0/xx
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of ES8704170A1 publication Critical patent/ES8704170A1/es
Publication of ES546916A0 publication Critical patent/ES546916A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1745—Unsaturated ethers containing halogen containing six-membered aromatic rings having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1787—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings and having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Testing Of Short-Circuits, Discontinuities, Leakage, Or Incorrect Line Connections (AREA)
  • Tests Of Electronic Circuits (AREA)
  • Measuring Leads Or Probes (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE GUANINA, DE FORMULA GENERAL (I), Y SUS SALES FISIOLOGICAMENTE ACEPTABLES O ISOMEROS OPTICOS DE LOS MISMOS. CONSISTE EN CONDENSAR UN COMPUESTO DE FORMULA GENERAL (II) A LA POSICION N-9 DE UN DERIVADO DE GUANINA, DE FORMULA GENERAL (III). DICHA REACCION SE LLEVA A CABO A UNA TEMPERATURA COMPRENDIDA ENTRE CERO Y 100 GRADOS, DURANTE UN TIEMPO DE 1 HORA A TRES DIAS Y EN PRESENCIA DE UN CATALIZADOR BASICO. DE APLICACION EN LA PREPARACION DE COMPOSICIONES FARMACEUTICAS UTILIZADAS EN COMBATIR SELECTIVAMENTE LOS VIRUS, TALES COMO VIRUS DE HERPES, CAPACES DE PRODUCIR ENFERMEDADES CANCERIGENAS.
ES546916A 1983-12-20 1985-09-12 Un procedimiento para preparar derivados de guanina Expired ES8704170A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8307051A SE8307051D0 (sv) 1983-12-20 1983-12-20 Novel derivatives of alkyl guanine novel derivatives of alkyl guanine
SE8307052A SE8307052D0 (sv) 1983-12-20 1983-12-20 Novel derivatives of guanine novel derivatives of guanine

Publications (2)

Publication Number Publication Date
ES8704170A1 true ES8704170A1 (es) 1987-03-16
ES546916A0 ES546916A0 (es) 1987-03-16

Family

ID=26658599

Family Applications (3)

Application Number Title Priority Date Filing Date
ES538721A Expired ES8609325A1 (es) 1983-12-20 1984-12-18 Un procedimiento para preparar derivados de guanina
ES546916A Expired ES8704170A1 (es) 1983-12-20 1985-09-12 Un procedimiento para preparar derivados de guanina
ES554546A Expired ES8800946A1 (es) 1983-12-20 1986-04-30 Un procedimiento para preparar derivados de guanina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES538721A Expired ES8609325A1 (es) 1983-12-20 1984-12-18 Un procedimiento para preparar derivados de guanina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES554546A Expired ES8800946A1 (es) 1983-12-20 1986-04-30 Un procedimiento para preparar derivados de guanina

Country Status (20)

Country Link
US (1) US4798833A (es)
EP (2) EP0146516A3 (es)
JP (1) JPH0667939B2 (es)
KR (1) KR910010048B1 (es)
AU (1) AU586415B2 (es)
CA (1) CA1285560C (es)
DE (1) DE3477568D1 (es)
DK (1) DK159683C (es)
ES (3) ES8609325A1 (es)
FI (1) FI80885C (es)
GB (1) GB2151622B (es)
GR (1) GR82499B (es)
HU (1) HU193595B (es)
IE (1) IE57913B1 (es)
IL (1) IL73682A (es)
IS (1) IS1507B (es)
MY (1) MY102565A (es)
PH (1) PH21410A (es)
PT (1) PT79714B (es)
WO (1) WO1985002845A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
US5684153A (en) * 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
CA1288098C (en) * 1984-08-24 1991-08-27 Richard L. Tolman 4-(guanin-9-yl)butanals and their 3-oxa, 3-thia and 2-ene derivatives having antiviral and antitumor activity
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
EP0219838A3 (en) * 1985-10-22 1988-04-06 Takeda Chemical Industries, Ltd. Carbocyclic purine nucleosides, their production and use
US5066655A (en) * 1987-04-24 1991-11-19 Whitby Research, Inc. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US5175288A (en) * 1987-08-01 1992-12-29 Beecham Group P.L.C. Process for preparing purine derivatives and intermediates thereof
US4935427A (en) * 1987-12-31 1990-06-19 The United States Of America As Represented By The Department Of Health And Human Services Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents
US5284837A (en) * 1988-05-06 1994-02-08 Medivir Ab Derivatives of purine, process for their preparation and a pharmaceutical preparation
SE8801729D0 (sv) * 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
GB8817607D0 (en) * 1988-07-23 1988-09-01 Beecham Group Plc Novel process
GB8822236D0 (en) * 1988-09-21 1988-10-26 Beecham Group Plc Chemical process
CA2009109A1 (en) * 1989-02-02 1990-08-02 John Hannah Antiviral acyclonucleosides and acyclonucleotides
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB8922076D0 (en) * 1989-09-28 1989-11-15 Beecham Group Plc Novel process
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
US5674869A (en) * 1990-07-07 1997-10-07 Beecham Group Plc Pharmaceutical treatment
WO1995000515A1 (en) * 1993-06-23 1995-01-05 Merrell Pharmaceuticals Inc. Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
GB9615276D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
ES2138535B1 (es) * 1996-07-20 2000-11-16 Smithkline Beecham Plc Procedimiento para la preparacion de los compuestos antivirales penciclovir y famciclovir.
GB9615253D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
GB9807114D0 (en) 1998-04-02 1998-06-03 Smithkline Beecham Plc Novel process
WO2021209563A1 (en) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
CA1305138C (en) * 1981-08-11 1992-07-14 Howard J. Schaeffer Antiviral acyclic nucleoside derivatives and their preparation
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
EP0141927B1 (en) * 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.

Also Published As

Publication number Publication date
WO1985002845A1 (en) 1985-07-04
GR82499B (en) 1985-04-19
EP0146516A2 (en) 1985-06-26
DK362585D0 (da) 1985-08-09
HUT37619A (en) 1986-01-23
FI853171L (fi) 1985-08-19
IS1507B (is) 1992-09-29
HU193595B (en) 1987-11-30
CA1285560C (en) 1991-07-02
IE843261L (en) 1985-06-20
DK362585A (da) 1985-08-09
GB2151622A (en) 1985-07-24
IL73682A (en) 1991-08-16
MY102565A (en) 1992-07-31
ES554546A0 (es) 1987-12-01
EP0146516A3 (en) 1985-08-14
GB8431910D0 (en) 1985-01-30
ES546916A0 (es) 1987-03-16
KR850700136A (ko) 1985-10-25
IS2966A7 (is) 1985-06-21
AU3787385A (en) 1985-07-12
DK159683C (da) 1991-04-15
GB2151622B (en) 1988-05-11
EP0165289B1 (en) 1989-04-05
DE3477568D1 (en) 1989-05-11
PT79714A (en) 1985-01-01
FI853171A0 (fi) 1985-08-19
PH21410A (en) 1987-10-15
FI80885C (fi) 1990-08-10
EP0165289A1 (en) 1985-12-27
IL73682A0 (en) 1985-02-28
IE57913B1 (en) 1993-05-19
ES8609325A1 (es) 1986-09-01
ES8800946A1 (es) 1987-12-01
DK159683B (da) 1990-11-19
US4798833A (en) 1989-01-17
FI80885B (fi) 1990-04-30
PT79714B (en) 1986-12-30
JPS61500730A (ja) 1986-04-17
AU586415B2 (en) 1989-07-13
ES538721A0 (es) 1986-09-01
JPH0667939B2 (ja) 1994-08-31
KR910010048B1 (ko) 1991-12-12

Similar Documents

Publication Publication Date Title
ES8609325A1 (es) Un procedimiento para preparar derivados de guanina
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
SE8406538D0 (sv) Novel derivatives of purine
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
DE3174948D1 (en) Novel derivatives of guanine
SE8300623L (sv) Farmaceutisk komposition innehallande stabil mikrokristallin cis-platina(ii)-diammindiklorid (cisplatin)
FI945625A0 (fi) Indolokarbatsoli-imidit ja niiden käyttö
IT8248200A0 (it) Preparato farmaceutico per la cura del diabete mellitus
HUT52040A (en) Process for producing diaryl-derivatives and pharmaceutical compositions containing them
NO870560D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ES8400742A1 (es) Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co.
AU584235B2 (en) New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them
KR870007098A (ko) 플루오르화 디아미노알킨유도체 및 이의 제조방법
YU169090A (sh) Tetra hidroimidazo (1,4) benzodiazepini
ES8106496A1 (es) Un procedimiento para la preparacion de disulfoderivados
NO890477D0 (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse av 9-(1,3-dihydroksy-2-propoksymetyl)guanin.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070127